Hebing Chen
Impact in
- Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Metabolomics and Mass Spectrometry Studies
- RNA modifications and cancer
- Bioinformatics and Genomic Networks
- RNA and protein synthesis mechanisms
- Pharmacology top 5%
- Plant-based Medicinal Research
Papers in
-
- Cancer Genomics and Diagnostics 6
-
- Genomics and Chromatin Dynamics 23
- Epigenetics and DNA Methylation 10
- RNA modifications and cancer 10
- Bioinformatics and Genomic Networks 8
- Single-cell and spatial transcriptomics 7
- RNA Research and Splicing 7
- Metabolomics and Mass Spectrometry Studies 4
- Co-authors
- Xiaochen BoWenjie ShuShengqi WangXianzhong YanCheng QuanShuai JiangHao LiXin Huang
- Journals
- Nature Communications (5 papers)Briefings in Bioinformatics (4 papers)PLoS ONE (4 papers)Nucleic Acids Research (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hebing Chen
60 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 120
- Molecular Biology 857
- Pharmacology 94
- Cancer Research 148
- Complementary and alternative medicine 70
- Biological Psychiatry 16
Countries citing papers authored by Hebing Chen
This map shows the geographic impact of Hebing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hebing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hebing Chen more than expected).
Fields of papers citing papers by Hebing Chen
This network shows the impact of papers produced by Hebing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hebing Chen. The network helps show where Hebing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hebing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 13 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 31 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 23 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 36 | |
| 15 | 2022 | 19 | |
| 16 | 2022 | 19 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 50 | |
| 19 | 2019 | 2 | |
| 20 | 2019 | 6 |
About Hebing Chen
Hebing Chen is a scholar working on Cancer Research, Molecular Biology, Aging, Filtration and Separation and Pharmacology, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (23 papers), Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (10 papers), Bioinformatics and Genomic Networks (8 papers), Single-cell and spatial transcriptomics (7 papers), RNA Research and Splicing (7 papers), Cancer Genomics and Diagnostics (6 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). The work is most often cited by research in Molecular Biology (857 citations), Pharmacology (94 citations), Cancer Research (148 citations), Complementary and alternative medicine (70 citations) and Biological Psychiatry (16 citations). Hebing Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiaochen Bo, Wenjie Shu, Shengqi Wang, Xianzhong Yan, Cheng Quan, Shuai Jiang, Hao Li, Xin Huang, Wanying Li and Ruijiang Li. Their work appears in journals such as Nature Communications, Briefings in Bioinformatics, PLoS ONE, Nucleic Acids Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.